Focus: CENTOGENE is a Germany-based biotechnology company specializing in genetic testing and biomarker discovery for rare diseases. The company operates a focused pipeline of 30 biomarker and diagnostic programs targeting ultra-rare lysosomal storage and genetic disorders.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
CENTOGENE is a specialized rare disease biomarker shop best suited for scientists seeking deep expertise over near-term exit potential; financial transparency and hiring scale warrant investigation before joining.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CENTOGENE
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CENTOGENE's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles